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Summary: The effect of ascorbic acid on neutrophil functions was investigated.
The chemiluminescence of isolated neutrophils, stimulated with N-fonnyl-L-methionyl-L-leucyl-L-phenylal-
anine, latex, lipopolysaccharide from Escherichia coli, zymosan A, or 4 -phorbol 12 -myristate 13a-acetate
was inhibited up to 99% by the dose-dependent oxygen radical scavenging activity of 6 mmol/1 ascorbic acid.
The chemiluminescence of neutrophils in blood, stimulated with 4 -phorbol 12 -myristate 13a-acetate, or
with zymosan A was inhibited 35% or 48%, respectively, by 6 mmol/1 ascorbic acid.
Ascorbic acid, up to 6 mmol/1, did not inhibit the release of -N-acetylglucosaminidase and elastase from
isolated neutrophils activated by the above stimulatory agents.
During neutrophil/nylon fibre interaction ascorbic acid reduced the oxygen radical production dose-depend-
ently (77% inhibition of the chemiluminescence response at 6 mmol/1 ascorbic acid), whereas the adherence
was unaffected. Hypoxanthine/xanthine oxidase-generated oxygen radicals were scavenged by ascorbic acid
in a dose-dependent manner (99% inhibition of the chemiluminescence response at 100 μιηοΐ/ΐ ascorbic acid).
From these results, ascorbic acid can highly be recommended for animal experiments and clinical studies in
patients with trauma, shock and sepsis and for studies to prevent or reduce reperfusion injuries.
Introduction . , , ., , , * * , . , .
activated neutrophils and by the endothelial intra-
Oxygen-derived free radicals are increasingly recog- cellular route by the hypoxanthine/xanthine oxidase1)
nized as the major cause of mono or multiple organ system. Many experimental data show the beneficial
failure, and for reperfusion injury in different organs effect of an antioxidant treatment to prevent or to
(1-3). These radicals are produced extracellularly by minimize oxidant-mediated tissue damage; such an-
tioxidants include allopurinol, oxypurinol, tungsten,
Superoxide dismutase1), catalase1), dimethyl sulphox-
) Enzymes , . . ., _ -Λ Λ j ο η ι ide, desferrioxamine, lactoferrin, transferrin, N-ace--N-acetylglucosamimdase, 2-acetamido-2-deoxy-b-Z)-glu- Λ . ,. , « , . , , . .,
coside acetamido-deoxyglucohydrolase (EC 3.2.1.30) tylcysteme, dimethyl thiourea, dihydrobenzoic acid,
catalase, hydrogen-peroxiderhydrogen-peroxide oxidoreduc- glutathione, -carotene and oc-tocopherol. Surpris-
tase (EC 1.11.1.6) ,«-,„. ~, ™ ingly, the naturally occurring non-toxic compound,
elastase, leukocyte, lysosomal elastase (EC 3.4.21.37) \. - j · ι · « · - j ·
L-gulonolactone oxidase, L-gulono-y-lactoneioxygen 2-oxi- ascorbic acid with its excellent antioxidative proper-
doreductase (EC 1.1.3.8) ties has not attracted attention in this context with
(EcTr5diei)SmUtaSe'superoxide:superoxideoxidoreductase the recent exception of the evaluation of its role in
xanthine' oxidase, xanthine:oxygen oxidoreductase (EC the modulation of oxidant stress mediated by cigarette
1.2.3.2) smoke-activated phagocytes (4). Furthermore, an-
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other report has described ascorbic acid as the most
effective antioxidant in human blood plasma in rela-
tion to lipid peroxidation (5), and the authors sug-
gested that ascorbic acid should prove very helpful in
the treatment and prevention of diseases and degen-
erative processes caused by oxidative stress.
Due to an evolutionary defect of the L-gulonolactone
oxidase gene, which arose about 60 million years ago,
man and some other species are unable to biosyn-
thesize ascorbic acid. It has been calculated that the
hypothetical endogenous synthesis capacity of a 70 kg
person increases up to 15 g/day under stress, repre-
senting the quantity needed for the array of different
protective and host defence functions, but which is
never be attained by enteral intake (6). Thus, in ex-
treme oxidative stress situations the infusion of in-
creased amounts of ascorbic acid seems to be neces-
sary and advisable.
Therefore, to substantiate this idea experimentally
and to obtain data on the potentially beneficial use
of ascorbic acid in organ failure diseases like the adult
respiratory distress syndrome (ARDS), we investi-
gated the effect of ascorbic acid on the oxygen radical
formation of activated neutrophils and the hypoxan-
thine/xanthine oxidase system. Furthermore, the in-
fluence of ascorbic acid on pathophysiologically im-
portant functions of neutrophils, like the lysosomal
enzyme release and adherence, was also monitored.
Materials and Methods
Chemicals and reagents
E. Merck, Darmstadt, Germany: Turk's solution for leukocyte
counting; digitonin; test combination PMN Elastase, IMAC;
L(+)-ascorbic acid.
Pharmacia Fine Chemicals, Sweden: Percoll for density gradient
centrifugation.
Boehringer, Mannheim, Germany: luminol; lucigenin; Minimal
Essential Medium Dulbecco for chemiluminescence.
Laboratorium Prof. Dr. Berthold, Wildbad, Germany: 3.5 ml
polystyrene vials for chemiluminescence.
Sigma Chemie GmbH, Deisenhofen, Germany: zymosan A
from Saccharomyces cerevisiae yeast; 4-methylumbelliferyl-N-
acetyl- -D-glucosaminide; 4-methylumbelliferone; 4 -phorbol
12 -myristate 13a-acetate; N-formyl-L-methionyl-L-leucyl-L-
phenylalanine; lipopolysaccharide from Escherichia coli sero-
type No. 055:B5, phenol extract; xanthine oxidase, grade I from
buttermilk, 0.47 units/mg protein, 16.7 kU/1, protein 38 g/1.
Blood bank, Medizinische Hochschule Hannover, Germany:
venous blood from male donors anticoagulated with 31.3 g/1
sodium citrate solution (9 vol of blood + 1 vol of citrate so-
lution); pool plasma was obtained after centrifugation at 1500 g
and room temperature for 10 minutes.
Fluka, Switzerland: Nonidet P40 (ethylphenylpolyethylenegly-
col, NP40).
Fenwal, Division of Travenol Laboratories, Inc. Deerfield, IL,
USA: nylon fiber from Leuko-Pak Leukocyte Filter, Code 4C
2401.
Fresenius, Bad Homburg, Germany: sodium citrate solution
31.3 g/1.
Serva, Heidelberg, Germany: latex, Unisphere latex 22, 0.777
μηι diameter, 10%.
Riedel-de Haen, Seelze-Hannover, Germany: hypoxanthine.
Chemiluminescence of neutrophi ls
Neutrophils were isolated from citrated blood as previously
described (7). Briefly, for the chemiluminescence response the
chemiluminescence vials contained the following solutions (vol-
umes of blanks in brackets): 485 μΐ (505 μΐ) Minimal Essential
Medium, 10 μΐ (10 μΐ) luminol (final concentration 0.4 mmol/1),
20 μΐ (20 μΐ) pool plasma, 10 μΐ (10 μΐ) ascorbic acid (final
concentration 0 — 6 mmol/1), 20 μΐ (Ο μΐ) stimulant (final con-
centration N-fonnyl-L-methionyl-L-leucyl-L-phenylalanine 3.5
μηιοΐ/ΐ, latex 1.75 ml/1, lipopolysaccharide 7 μg/l, zymosan A
3.5 g/l, 4 -phorbol 12 -myristate 13a-acetate 5 μπιοΐ/ΐ), and
25 μΐ (25 μΐ) neutrophil suspension in Minimal Essential Me-
dium with 25 000 cells.
For chemiluminescence measurements of blood the reaction
mixtures were composed as follows: 500 μΐ (510 μΐ) Minimal
Essential Medium, 10 μΐ (10 μΐ) luminol (final concentration 0.4
mmol/1), 10 μΐ (10 μΐ) ascorbic acid (final concentration 0 — 6
mmol/1), ΙΟ μΙ (Ο μΐ) 4 -phorbol 12 -myristate 13a-acetate (fi-
nal concentration 5 μηιοΙ/1) or zymosan (final concentration 3.5
g/l), and 40 μΐ (40 μΐ) citrated blood.
Neutrophils were counted in a Neubauer haemocytometer after
staining with Turk's solution.
Replicates and blanks were started simultaneously in a six
channel biolurnat LB 9505 (Berthold, Wildbad, Germany), the
photon emission was recorded continuously for 60 minutes, the
peak maximum values of the blanks were subtracted from the
stimulation values and the photon emission was referred to
25 000 cells (chemiluminescence measurement of isolated neu-
trophils) and to 200 000 cells (chemiluminescence measurement
of citrated blood), respectively.
Enzyme release from neutrophils
The enzyme release was measured as follows. Isolated neutro-
phils were suspended in Minimal Essential Medium at about
4 · 109/1; the reaction mixtures contained: 520 μΐ (520 μΐ) neu-
trophil suspension, Ο μΐ (20 μΐ) Minimal Essential Medium,
20 μΐ (20 μΐ) pool plasma, 10 μΐ (10 μΐ) ascorbic acid (final
concentration 0 — 6 mmol/1), and 20 μΐ (Ομί) stimulant (final
concentration as described in the section 'Chemiluminescence
of neutrophils'). Immediately after starting by the addition of
the stimulant, a 100 μΐ aliquot of the reaction mixture was
removed and added to 100 μΐ digitonin/Nonidet P40 to lyse the
neutrophils for the determination of the total content of
elastase1) and -N-acetylglucosaminidase1) (7). After 45 minutes
at 37 °C the remaining reaction mixture was centrifuged at
12000g and room temperature for 1 minute. The supernatant
was removed and analysed for -N-acetylglucosaminidase spec-
trofluorimetrically (7) and for elastase by the IMAC test. The
percentage of enzyme released was calculated.
Nylon fibre adherence and chemiluminescence of neu-
trophils
For the determination of the nylon fibre adherence and adher-
ence-induced and lucigenin-enhanced chemiluminescence re-
sponse a modification of the previously described test procedure
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 30,1992 / No. 4
Dwenger et al.: Ascorbic acid and neutrophil functions 189
(8) was used: replicates of 100 μΐ (100 μΐ) citrated blood, 450
μΐ (450 μΐ) Minimal Essential Medium, 10 μΐ (10 μΐ) lucigenin
(final concentration 0.23 mmol/1), 10 μΐ (ΙΟμΙ) ascorbic acid
(final concentration 0 — 6 mmol/1) were incubated for 30 min-
utes at 37 °C with (A) and without (B) 5 mg of nylon fibre. The
photon emission was recorded during incubation. Then the
nylon fibre was removed, neutrophils (PMNL) were counted
in A and Β using a haemocytometer after staining with Turk's
solution, the adherence was calculated by the formula
Adherence = PMNL/IB - PMNL/U
PMNL/lb
(9)
and the photon emission (peak maximum) was referred to only
adhered cells after subtract!ve correction for the blank.
Chemiluminescence of the hypoxan th ine /xan th ine
oxidase system
To 470 μΐ phosphate buffer (100 mmol/1, pH 7.4) with ethyl-
enediaminetetraacetate (1 mmol/1) and luminol (0.23 mmol/1)
were added 10 μΐ hypoxanthine (final concentration 0.2
mmol/1), 10 μΐ ascorbic acid (final concentration 0—1 mmol/1)
and 10 μΐ xanthine oxidase (final concentration 0.68 U/l). The
photon emission was recorded for 1 minute, and the peak
maximum values were determined for each ascorbic acid con-
centration.
Statistics
The data are expressed as mean ± SEM. Statistical compari-
sons were performed by Student's t-test for paired data and
Wilcoxon's matched pairs signed rank test, respectively. The
null hypothesis was rejected for p < 0.05.
Results
Figure 1 exhibits the chemiluminescence response of
isolated neutrophils activated by different stimuli in
the absence and presence of different concentrations
of ascorbic acid. Despite the very different absolute
amounts of oxygen radicals produced by these stimuli
(fig. la) there was a comparable dose-dependent re-
duction of the chemiluminescence response beginning
at 0.6 mmol/1 ascorbic acid for all stimuli (fig. Ib).
There was no dose-dependent inhibition of the -N-
acetylglucosaminidase (fig. 2). and elastase (fig. 3)
release from isolated neutrophils after stimulation
with N-formyl-L-methionyl-L-leucyl-L-phenylala-
nine, latex, lipopolysaccharide, zymosan and 4 -phor-
bol 12 -myristate 13a-acetate. On the contrary, a
slight dose-dependent increase of -N-acetylglucosa-
minidase was observed after stimulation with zymo-
san or 4 -phorbol 12 -myristate 13oc-acetate (fig. 2)
and of elastase after stimulation with 4 -phorbol 12 -
myristate 13oc-acetate (fig. 3).
The chemiluminescence response of blood was inhib-
ited dose-dependently by ascorbic acid after stimula-
tion with 4 -phorbol 12 -myristate 13a-acetate (fig.




























Fig. 1. Chemiluminescence response of isolated human neutro-
phils stimulated with N-formyl-L-methionyl-L-leucyl-L-
phenylalanine, latex, lipopolysaccharide from Esche-
richia coli, zymosan A and 4 -phorbol 12 -myristate
13oc-acetate in the absence and presence of different
ascorbic acid concentrations
(D 0 mmol/1 Ώ 0.06 mmol/1 S 0.6 mmol/1 · 6.0
mmol/1)
a data calculated as 106 counts/min per 25000 poly-
morphonuclear leukocytes (χ; η = 3)
b data referred to 0 mmol/1 ascorbic acid (x ± SEM;
n = 3)



















Fig. 2. -N-Acetylglucosaminidase release from isolated hu-
man neutrophils (χ ± SEM; n = 3) stimulated with the
stimuli described in figure 1 in the absence and presence
of different ascorbic acid concentrations
(D 0 mmol/1 E3 0.06 mmol/1 B 0.6 mmol/1 · 6.0
mmol/1)
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Fig. 3. Elastase release from isolated human neutrophils
(χ ± SEM, n = 3) stimulated with the stimuli described
in figure 1 in the absence and presence of different
ascorbic acid concentrations







Fig. 4. Chemiluminescence response of blood (x ± SEM,
n = 5) exposed to 5 μηιοΐ/ΐ 4 -phorbol 12 -myristate
13a-acetate in dependency on the ascorbic acid concen-
tration
* p < 0.05 data vs 0.012 mmol/1 data
0.01 0.1 1
Ascorbic acid [mmol/l]
Fig. 5. Chemiluminescence response of blood (x ± SEM;
n = 6) exposed to 3.5 g/1 zymosan in dependency on
the ascorbic acid concentration

































Fig. 6. Adherence and Chemiluminescence response (ΙΟ6 counts/
min per 25000 polymorphonuclear leukocytes) by the
interaction of blood and nylon fibre (χ ± SEM; n = 4)
in dependency on the ascorbic acid concentration






Fig. 7. Inhibition of the hypoxanthine (0.2 mmol/l)/xanthine
oxidase (0.68 U/l) -generated oxygen radicals in de-
pendency on the ascorbic acid concentration (x + SEM;
n = 3)
* p < 0.05 data vs 0.2 μπιοΐ/ΐ data
During adherence of neutrophils to nylon fibre, as-
corbic acid reduced the Chemiluminescence response
in a dose-dependent manner, whereas there was no
concomitant alteration of the adherence (fig. 6).
Hypoxanthine/xanthine oxidase-generated oxygen
radicals showed photon emission curves which were
totally suppressed by ascorbic acid. The dose-depend-
ency demonstrated a complete radical scavenging at
ascorbic acid concentrations greater than 100 μιηοΐ/ΐ
(fig- 7).
Discussion
Studies by many laboratories have shown a protective
effect of different antioxidants against ischemia/re-
perfusion injury and organ failure. In this report the
dose-dependent effect of ascorbic acid has been shown
to scavenge oxygen radicals produced by both systems
involved in such tissue damage processes:
(i) the activated neutrophil, and
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(ii) the hypoxanthine/xanthine oxidase system of e. g.
endothelial cells.
The oxygen radical production of the latter system
was completely inhibited by small concentrations of
ascorbic acid, whereas the incomplete scavenging of
respiratory burst-generated oxygen radicals of neu-
trophils varied in dependence on the stimulus, and
higher doses of ascorbic acid were required. This may
be a result of the intracellularly produced portion of
oxygen radicals which is normally inaccessible for the
extracellular ascorbic acid. But one could conceivably
increase the intracellular ascorbic acid concentration
by insulin, since ascorbic acid/dehydroascorbic acid
and glucose seem to use an identical transport system
in human neutrophils (10). Concerning further neu-
trophil functions, our data demonstrated that the
adherence of neutrophils to nylon fibre was not influ-
enced, even by high concentrations of ascorbic acid
that produced a nearly complete reduction of the
simultaneously observed oxygen radical production.
Also the release of lysosomal enzymes was generally
unaffected by ascorbic acid, but there was a slight
dose-dependent increase of the ß-N-acetylglucosamin-
idase release when zymosan or 4ß-phorbol 12ß-myr-
istate 12oc-acetate was used for activation, and of the
elastase release when 4ß-phorbol 12ß-myristate 13 -
acetate was used for activation. We cannot explain
this observation.
In view of its excellent antioxidative properties which
are highly important for several biochemical pathways
(6, 11) and its non-toxic character, ascorbic acid
should primarily be recommended as a supplement in
animal experiments and clinical studies in patients
with trauma, shock and sepsis, i. e. it should be used
in the same as other antioxidants like N-acetylcysteine
(12). Furthermore, ascorbic acid can also be recom-
mended for trials to prevent or to reduce reperfusion
injuries.
In preliminary experiments we found that sheep tol-
erated high doses of ascorbic acid intravenously
(1 g/kg b. w. as a bolus injection followed by a con-
tinuous infusion of 0.2 g/kg · h for 5 hours produced
a 50 fold increase of the normal plasma concentra-
tion). Experiments are currently being performed in
our laboratory on the use of ascorbic acid to prevent
the endotoxin-induced pulmonary dysfunction in the
sheep model according to Staub et al. (13).
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